Mycirq (Ethinylestradiol, Etonogestrel)

Ethinylestradiol, the active ingredient in Mycirq, is a combined estrogen‑progestogen contraceptive presented as a vaginal ring for vaginal use. Together with etonogestrel, it provides continuous hormone delivery that suppresses ovulation and alters cervical mucus, thereby preventing pregnancy in women of reproductive age.

GNH USA supplies Mycirq as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides regulatory documentation for importers. Products are shipped in tamper‑evident packaging with temperature monitoring to ensure product integrity.

Mycirq, a combined estrogen‑progestogen contraceptive, is indicated for hormonal contraception.

- Contraception: prevents unintended pregnancy in women of reproductive age. - Family planning: offers a reversible, user‑controlled method for birth control. - Prevention of pregnancy: reduces the risk of conception during regular use.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or soreness. - Vaginal irritation: redness or discomfort at the ring site.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Severe allergic reaction (anaphylaxis): rapid onset of hives, swelling, and breathing difficulty.

Before prescribing Mycirq, consider the following precautions: - Pregnancy contraindication: do not use in women who are or may become pregnant. - Smoking restriction: avoid in smokers over 35 years of age due to increased thrombotic risk. - Thrombotic history: assess for prior clotting disorders or cardiovascular disease. - Blood pressure monitoring: check regularly during use. - Missed ring removal: advise prompt removal and medical consultation if the ring is left in place beyond the recommended period. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Mycirq may interact with other medicines as follows:

Major Interactions (Avoid): - Rifampin: enzyme induction can markedly reduce contraceptive effectiveness. - Phenytoin: hepatic enzyme induction may lower hormone levels. - St. John’s wort: herbal induction may compromise contraceptive reliability.

Moderate Interactions (Monitor Closely): - Antihypertensives: hormonal changes may alter blood pressure control. - Selective serotonin reuptake inhibitors (SSRIs): may increase the incidence of mood‑related side effects.